OPHLY OTC
Ono Pharmaceutical Co., Ltd.
1W: -6.1%
1M: -6.8%
3M: -4.0%
YTD: +5.5%
1Y: +26.6%
3Y: -18.4%
5Y: -34.4%
$4.80
-0.04 (-0.85%)
Weekly Expected Move ±5.2%
$4
$5
$5
$5
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$145.1B
+75.9% ▲
5Y CAGR: +14.4%
Capital Expenditures
$6.4B
+20.1% ▲
5Y CAGR: -20.6%
Free Cash Flow
$138.7B
+86.2% ▲
5Y CAGR: +20.9%
Dividends Paid
$39.8B
-6.1% ▼
Buybacks
$1M
-6.0% ▼
Net Change in Cash
$19.5B
-49.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $105.0B | $143.5B | $128.0B | $59.3B | $74.0B |
| Depreciation & Amort. | $17.7B | $17.5B | $18.1B | $26.9B | $40.0B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$30.1B | $1.4B | -$29.0B | $38.3B | $22.8B |
| Other Non-Cash Items | -$30.8B | -$2.8B | -$6.5B | -$42.1B | $8.3B |
| Operating Cash Flow | $61.8B | $159.6B | $110.7B | $82.5B | $145.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$12.3B | -$14.5B | -$4.0B | -$5.4B | -$56.5B |
| Acquisitions (Net) | -$6.8B | -$9.2B | $0 | -$364.8B | $22M |
| Investment Purchases | -$58.6B | -$140.6B | -$36.7B | -$4.1B | -$4.7B |
| Investment Sales | $78.6B | $55.9B | $106.0B | $240.8B | $19.8B |
| Other Investing | $5.1B | $8.1B | -$17.2B | -$3.3B | -$895M |
| Investing Cash Flow | $6.0B | -$100.3B | $48.1B | -$136.8B | -$42.3B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $135.0B | -$26.1B |
| Stock Repurchased | -$30.0B | -$1M | -$50.0B | -$1M | -$1M |
| Dividends Paid | -$27.7B | -$29.7B | -$37.2B | -$37.5B | -$39.8B |
| Other Financing | -$2.6B | -$2.7B | -$2.7B | -$3.2B | -$3.6B |
| Financing Cash Flow | -$60.2B | -$32.5B | -$89.8B | $94.3B | -$69.4B |
| Net Change in Cash | $8.1B | $27.0B | $70.0B | $38.4B | $19.5B |
| Cash End of Period | $69.1B | $96.1B | $166.1B | $204.6B | $238.1B |
| Free Cash Flow | $49.6B | $145.1B | $89.8B | $74.5B | $138.7B |